thrombolytic drug


Also found in: Dictionary, Thesaurus, Medical, Wikipedia.
Related to thrombolytic drug: Anticoagulant drug

thrombolytic drug

thrombolytic drug (thrŏmˌbəlĭtˈĭk) or clot-dissolving drug, substance, such as streptokinase or tissue plasminogen activator (tPA), that causes the breakdown of blood clots (see thrombosis) that obstruct the flow of blood through the vessels. Its uses include injection during or shortly after a heart attack or stroke (see infarction) to prevent clots from blocking blood flow to the heart muscle or brain.
The Columbia Electronic Encyclopedia™ Copyright © 2022, Columbia University Press. Licensed from Columbia University Press. All rights reserved.
References in periodicals archive ?
TABLE 1 Generation of Fibrin specific Nonfibrin specific thrombolytic drug First Urokinase * Streptokinase * Second Recombinant tissue Prourokinase plasminogen activator * (scum-PA) (t-PA) Sk-plasminogen Alteplase activating complex * (APSAC) Third Tenecteplase * (TNK-tPA) ...
The mechanical thrombolytic effect has been confirmed in several experimental studies of only microbubbles and ultrasound, without thrombolytic drugs [39-42].
With appropriate test chemistry, LOT provides a measure of in vitro fibrinolytic effects before the administration of a thrombolytic drug [6].
Until a few years ago, percutaneous coronary intervention (PCI) was contraindicated in patients with a thrombolytic drug on board, but today's widespread use of stents, thienopyridines, and glycoprotein IIb/IIIa inhibitors has made the routine use of PCI following lytic therapy a recommended strategy, C.
Thrombolytic drugs act to break down the blood clot which causes a heart attack, allowing oxygen to get to the heart muscle.
studies was the thrombolytic drug used; desmoteplase, a plasminogen activator derived from vampire bat saliva.
Each North-East Ambulance Service paramedic has a check list which they must follow before administering a thrombolytic drug.
It is protein and as it is bacterial product so human body has the ability to develop immunity against it.1 It was developed as a thrombolytic drug that was used earlier for haemothorax, pleural exudates, tuberculous meningitis treatment and then used for Myocardial infarction, pulmonary embolism and empyema.
This group of new products, added to the company's portfolio of angiographic catheters, thrombolytic drug delivery systems, electro-mechanical injectors, vascular access devices and carbon dioxide systems, places AngioDynamics as a full-service provider to the global Interventional Radiology community.
If intracranial bleeding is suspected, thrombolytic drug infusion must be stopped immediately, an emergent CT scan ordered and neurosurgical consultation obtained if the CT demonstrates hemorrhage.
The thrombolytic drug is now being administered by paramedics and doctors faster than before.